🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate the effectiveness of an anti...
Status
Enrolling By Invitation
Location
Universidad of Zaragoza
Start Date
2026-01-16
Trial ID
NCT07398040
Treatments Being Tested
Randomized controlled trial to further assess the impact of a digital inter...
Status
Unknown
Location
University of Turku
Start Date
2022-03-01
Trial ID
NCT05395988
Treatments Being Tested
The purpose of this research is to see how personal financial burden (finan...
Status
Recruiting
Location
Levine Cancer Insitute
Start Date
2025-06-27
Trial ID
NCT06945042
This study aims to test the effectiveness of virtual reality (VR) as a non-...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2017-04-12
Trial ID
NCT04942561
Treatments Being Tested
This study aims to implement two interventions to determine the most effect...
Status
Not Yet Recruiting
Location
Danfa Community
Start Date
2026-10-01
Trial ID
NCT07745517
This research project is designed to promote health among first-year colleg...
Status
Completed
Location
University of Minnesota
Start Date
2019-07-31
Trial ID
NCT03930524
In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Status
Completed
Location
Sihanouk Hospital Center of Hope
Start Date
2014-09
Trial ID
NCT02057796
Preterm birth is associated with significant and often life-long developmen...
Status
Unknown
Location
Universitätsklinik für Kinderheilkunde Neonatologie Inselspital
Start Date
2018-02-01
Trial ID
NCT03460496
Cervical cancer is the most common cancer in women under 35 years and is a ...
Status
Completed
Location
Department of Surgery and Cancer, St Mary's Campus, Praed Street, Imperial College London
Start Date
2015-02
Trial ID
NCT02363088
To evaluate the efficacy and safety of Hetrombopag in secondary prevention ...
Status
Not Yet Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2025-08-01
Trial ID
NCT07101627
Treatments Being Tested